Medications for COPD
Other names: Bronchitis with Airway Obstruction; Bronchitis, Chronic; Chronic Bronchitis; Chronic Obstructive Airway Disease; Chronic Obstructive Lung Disease; Chronic Obstructive Pulmonary Disease; Emphysema
See also: sub-topics
Drugs used to treat COPD
The following list of medications are in some way related to or used in the treatment of this condition.
Drug name | Rating | Reviews | Activity ? | Rx/OTC | Pregnancy | CSA | Alcohol |
---|---|---|---|---|---|---|---|
Symbicort | 7.5 | 45 reviews | Rx | ||||
Generic name: budesonide / formoterol systemic Drug class: bronchodilator combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Trelegy Ellipta | 5.8 | 103 reviews | Rx | ||||
Generic name: fluticasone / umeclidinium / vilanterol systemic Drug class: bronchodilator combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
prednisone | 7.4 | 15 reviews | Rx | ||||
Generic name: prednisone systemic Brand name: Rayos Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
montelukast Off-label | 7.5 | 10 reviews | Rx | ||||
Generic name: montelukast systemic Drug class: leukotriene modifiers For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information Off-label: Yes |
|||||||
Breztri Aerosphere | 9.5 | 2 reviews | Rx | ||||
Generic name: budesonide / formoterol / glycopyrrolate systemic Drug class: bronchodilator combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
fluticasone / umeclidinium / vilanterol | 5.7 | 104 reviews | Rx | ||||
Generic name: fluticasone / umeclidinium / vilanterol systemic Brand name: Trelegy Ellipta Drug class: bronchodilator combinations For consumers: dosage, interactions, side effects |
|||||||
Anoro Ellipta | 6.9 | 54 reviews | Rx | ||||
Generic name: umeclidinium / vilanterol systemic Drug class: bronchodilator combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Breo Ellipta | 6.9 | 35 reviews | Rx | ||||
Generic name: fluticasone / vilanterol systemic Drug class: bronchodilator combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Daliresp | 7.7 | 45 reviews | Rx | ||||
Generic name: roflumilast systemic Drug class: selective phosphodiesterase-4 inhibitors For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
budesonide / formoterol | 7.6 | 46 reviews | Rx | ||||
Generic name: budesonide / formoterol systemic Brand names: Symbicort, Breyna Drug class: bronchodilator combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Tudorza Pressair | 9.0 | 14 reviews | Rx | ||||
Generic name: aclidinium systemic Drug class: anticholinergic bronchodilators For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Incruse Ellipta | 2.9 | 20 reviews | Rx | ||||
Generic name: umeclidinium systemic Drug class: anticholinergic bronchodilators For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Stiolto Respimat | 6.5 | 30 reviews | Rx | ||||
Generic name: olodaterol / tiotropium systemic Drug class: bronchodilator combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Rayos | 10 | 1 review | Rx | ||||
Generic name: prednisone systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
aclidinium | 9.0 | 14 reviews | Rx | ||||
Generic name: aclidinium systemic Brand name: Tudorza Pressair Drug class: anticholinergic bronchodilators For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
fluticasone / vilanterol | 6.9 | 35 reviews | Rx | ||||
Generic name: fluticasone / vilanterol systemic Brand name: Breo Ellipta Drug class: bronchodilator combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
levalbuterol | 8.5 | 4 reviews | Rx | ||||
Generic name: levalbuterol systemic Brand names: Xopenex, Xopenex HFA, Xopenex Concentrate Drug class: adrenergic bronchodilators For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
roflumilast | 7.8 | 48 reviews | Rx | ||||
Generic name: roflumilast systemic Brand name: Daliresp Drug class: selective phosphodiesterase-4 inhibitors For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
umeclidinium / vilanterol | 6.8 | 55 reviews | Rx | ||||
Generic name: umeclidinium / vilanterol systemic Brand name: Anoro Ellipta Drug class: bronchodilator combinations For consumers: dosage, interactions, side effects |
|||||||
Bevespi Aerosphere | 7.5 | 5 reviews | Rx | ||||
Generic name: formoterol / glycopyrrolate systemic Drug class: bronchodilator combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Xopenex | 10 | 2 reviews | Rx | ||||
Generic name: levalbuterol systemic Drug class: adrenergic bronchodilators For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
olodaterol / tiotropium | 6.4 | 31 reviews | Rx | ||||
Generic name: olodaterol / tiotropium systemic Brand name: Stiolto Respimat Drug class: bronchodilator combinations For consumers: dosage, interactions, side effects |
|||||||
Striverdi Respimat | 5.5 | 4 reviews | Rx | ||||
Generic name: olodaterol systemic Drug class: adrenergic bronchodilators For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
umeclidinium | 2.8 | 21 reviews | Rx | ||||
Generic name: umeclidinium systemic Brand name: Incruse Ellipta Drug class: anticholinergic bronchodilators For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
Xopenex HFA | Rate | Add review | Rx | ||||
Generic name: levalbuterol systemic Drug class: adrenergic bronchodilators For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Frequently asked questions
Topics under COPD
- Alpha-1 Proteinase Inhibitor Deficiency (6 drugs)
- COPD, Acute (19 drugs)
- COPD, Maintenance (61 drugs)
Learn more about COPD
Care guides
- Acute Bronchitis
- Acute Bronchitis in Children
- Chronic Bronchitis
- Chronic Cough
- COPD (Chronic Obstructive Pulmonary Disease)
- Emphysema
Symptoms and treatments
Medicine.com guides (external)
Legend
Rating | For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |
---|---|
Activity | Activity is based on recent site visitor activity relative to other medications in the list. |
Rx | Prescription only. |
OTC | Over-the-counter. |
Rx/OTC | Prescription or Over-the-counter. |
Off-label | This medication may not be approved by the FDA for the treatment of this condition. |
EUA | An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
N | FDA has not classified the drug. |
Controlled Substances Act (CSA) Schedule | |
---|---|
M | The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication. |
U | CSA Schedule is unknown. |
N | Is not subject to the Controlled Substances Act. |
1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.